These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32713867)

  • 1. High platelet count as a poor prognostic factor for liver cancer patients without cirrhosis.
    Midorikawa Y; Takayama T; Higaki T; Aramaki O; Teramoto K; Yoshida N; Tsuji S; Kanda T; Moriyama M
    Biosci Trends; 2020 Nov; 14(5):368-375. PubMed ID: 32713867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis.
    Berardi G; Morise Z; Sposito C; Igarashi K; Panetta V; Simonelli I; Kim S; Goh BKP; Kubo S; Tanaka S; Takeda Y; Ettorre GM; Wilson GC; Cimino M; Chan CY; Torzilli G; Cheung TT; Kaneko H; Mazzaferro V; Geller DA; Han HS; Kanazawa A; Wakabayashi G; Troisi RI
    J Hepatol; 2020 Jan; 72(1):75-84. PubMed ID: 31499131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy.
    Wang ZX; Peng W; Zhang XY; Wen TF; Li C
    Medicine (Baltimore); 2021 Mar; 100(11):e24476. PubMed ID: 33725934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and surgical outcome of HCC patients with low platelet count.
    Kondo K; Chijiiwa Y; Otani K; Kai M; Ohuchida J; Chijiiwa K
    Hepatogastroenterology; 2012 Oct; 59(119):2269-72. PubMed ID: 23435142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased platelet distribution width predicts a worse prognosis in patients undergoing surgical resection for hepatocellular carcinoma.
    Yue CX; Liu YX; Yun ZY; Li N; Zhao CJ; Wang RT
    Cancer Biomark; 2019; 26(3):361-366. PubMed ID: 31594211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopenia: A prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy.
    Cheng YQ; Wang K; Zhang XP; Wei XB; Jiang YB; Hu YR; Mao FF; Guo WX; Shi J; Cheng SQ
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1214-1221. PubMed ID: 30402968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-resection recurrence of hepatocellular carcinoma in cirrhotic patients: Is thrombocytopenia a risk factor for recurrence?
    Shehta A; Han HS; Ahn S; Yoon YS; Cho JY; Choi YR
    Surg Oncol; 2016 Dec; 25(4):364-369. PubMed ID: 27916167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
    Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous splenectomy and hepatectomy in patients with hepatocellular carcinoma, hypersplenism and liver cirrhosis.
    Shi R; Zhang YM; Zhu ZJ; Deng YL; Pan C; Zheng H; Shen ZY
    Hepatogastroenterology; 2014; 61(133):1363-7. PubMed ID: 25436312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence.
    Ercolani G; Grazi GL; Ravaioli M; Del Gaudio M; Gardini A; Cescon M; Varotti G; Cetta F; Cavallari A
    Ann Surg; 2003 Apr; 237(4):536-43. PubMed ID: 12677151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?
    Santambrogio R; Kluger MD; Costa M; Belli A; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
    HPB (Oxford); 2013 Jan; 15(1):78-84. PubMed ID: 23216782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
    Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
    Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
    Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis.
    Lewis RH; Glazer ES; Bittenbinder DM; O'Brien T; Deneve JL; Shibata D; Behrman SW; Vanatta JM; Satapathy SK; Dickson PV
    J Gastrointest Cancer; 2019 Dec; 50(4):808-815. PubMed ID: 30117090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of platelet count in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria.
    Amano H; Tashiro H; Oshita A; Kobayashi T; Tanimoto Y; Kuroda S; Tazawa H; Itamoto T; Asahara T; Ohdan H
    J Gastrointest Surg; 2011 Jul; 15(7):1173-81. PubMed ID: 21512850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.
    Ishizawa T; Hasegawa K; Aoki T; Takahashi M; Inoue Y; Sano K; Imamura H; Sugawara Y; Kokudo N; Makuuchi M
    Gastroenterology; 2008 Jun; 134(7):1908-16. PubMed ID: 18549877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.